Procter & Gamble to cut 7,000 jobs to rein in costs as tariff uncertainty looms

June 5 (Reuters) – Procter & Gamble (PG.N), opens new tab said on Thursday it would cut 7,000 jobs, or about 6%, of its total workforce over the next two years, as part of a new restructuring plan to counter uneven consumer demand and higher costs due to tariff uncertainty.

The world’s largest consumer goods company also plans to exit some product categories and brands in certain markets, executives said at a Deutsche Bank Consumer Conference in Paris, adding the program could likely include some divestitures without giving detail.

The Pampers maker’s two-year restructuring plan comes when consumer spending is expected to remain pressured this year, and global consumer goods makers including P&G and Unilever (ULVR.L), opens new tab brace for a further hit to demand from even higher prices.

“This is not a new approach, rather an intentional acceleration of the current strategy…to win in the increasingly challenging environment in which we compete,” executives said.

President Donald Trump’s sweeping tariffs on trading partners have roiled global markets and led to fears of a recession in the U.S., the biggest market for P&G. The company imports raw ingredients, packaging materials and some finished products into the U.S. from China.

Trump’s trade war has cost companies more than $34 billion in lost sales and higher costs, a Reuters analysis showed, a toll that is expected to rise.

In April, the Tide detergent maker said it would raise prices on some products and that it was prepared to pull every lever in its arsenal to mitigate the impact of tariffs.

Pricing and cost cuts were the main levers, CFO Andre Schulten had said then.

On Thursday, Schulten and P&G’s operations head Shailesh Jejurikar acknowledged that the geopolitical environment was “unpredictable” and that consumers were facing “greater uncertainty.”

The company had about 108,000 employees as of June 30, 2024, and said the job cuts would account for roughly 15% of its non-manufacturing workforce.

P&G added that the restructuring plan would help simplify the organizational structure by “making roles broader” and “teams smaller”.

The plans to divest certain brands will also help adjust its supply chain in order to reduce costs, P&G said.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Dr. Reddy’s Laboratories shares rise 4%: Two factors fueling the rally today

Shares of Dr. Reddy’s Laboratories surged 4 percent on Thursday amid a rally in the broader market. 
The company’s announcement of a strategic collaboration with Alvotech to co-develop, manufacture, and commercialize a biosimilar version of Keytruda (pembrolizumab) for global markets helped the stock to trade in the green today. Adding to the momentum, HSBC upgraded Dr. Reddy’s to a ‘Buy’ from ‘Hold’, and raised its target price to Rs 1,445, up from Rs 1,235. 

The pharma stock rose 4% to Rs 1303.45 against previous close of Rs 1252.15 on BSE. Market cap of the firm climbed to Rs 1.07 lakh crore on BSE.

The stock has gained 11% in a year and risen 40.18% in two years. 

The share stands higher than the 5 day, 10 day, 20 day, 30 day, 50 day, 100 day and 200 day moving averages. 

Keytruda is a immunotherapy drug for the treatment of various cancers. It clcoked global sales of $29.5 billion in 2024. The collaboration brings together the biosimilar expertise of both companies and is likely to accelerate development timelines while broadening the global reach of the product.

Development, manufacturing, and commercialization of the drug will be handled collaboratively by Dr. Reddy’s and Alvotech, with shared expenses and responsibilities, according to the agreement. Both businesses will also be able to sell the biosimilar abroad, barring specific circumstances.

Meanwhile, according to broker HSBC’s statement, the type-2 diabetes medication semaglutide is anticipated to dramatically increase the company’s earnings per share (EPS) in key markets within a year after launch.

For semaglutide, the brokerage views Canada, Brazil, and India as important target markets where supply is now limited but demand is still high. In contrast to other generics, HSBC does not anticipate a significant drop in Semaglutide prices as a result of ongoing demand. Over the next two to four years, it predicts that the Semaglutide opportunity in these areas may almost treble.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Stock Market Highlights: Indices close higher after a rangebound session, Nifty above 24,600

The Indian market ended higher today after a largely rangebound session, with the Nifty closing above the 24,600 mark and broader markets continuing to outperform the benchmarks.

Quick-service restaurant (QSR) stocks witnessed strong buying interest, with Swiggy jumping 9% and Eternal Foods rising over 3%. Bharti Airtel advanced 2% following a positive brokerage note, while HDFC Bank closed 1% higher after SEBI approved the ₹12,500 crore IPO of its subsidiary, HDB Financial Services.

On the downside, AB Fashion slumped more than 10% after block deals worth nearly ₹1,000 crore. Alkem Laboratories and Tata Technologies also declined, while IEX managed to close in the green despite witnessing major block deals.

Shipbuilding and rail-related companies continued to attract buying interest. Garden Reach Shipbuilders climbed 6% and Cochin Shipyard added 3%. Among railway stocks, Ircon, Railtel, and RVNL rallied between 6% and 14%. Reliance Infrastructure soared 11% after the NCLAT suspended an insolvency order passed by the NCLT. PI Industries gained over 4% after its largest customer, Kuimai, raised its outlook.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Adani Airports raises $750 mn to refinance debt and expand six airports

Adani Airports Holdings Ltd (AAHL), a subsidiary of Adani Enterprises Ltd, has secured $750 million in external commercial borrowings from a consortium of international lenders. 

The funds will be used to refinance $400 million in existing debt, with the remainder allocated for capital expenditure at six airports and AAHL’s non-aeronautical businesses, Adani Enterprises said in a stock exchange filing on Wednesday. 

The financing round was led by First Abu Dhabi Bank, Barclays, and Standard Chartered Bank. 

“The trust placed in us by leading global financial institutions underscores the long-term value and potential of India’s aviation infrastructure. AAHL is well on its path to deliver exceptional customer experiences, leveraging technology for seamless operations, and prioritising sustainability and community engagement across its airport network,” said Arun Bansal, Chief Executive Officer of AAHL.

Focus on six key airports and non-aero revenue streams

The six airports in focus are located in Ahmedabad, Lucknow, Mangaluru, Jaipur, Guwahati and Thiruvananthapuram. AAHL plans to use the funds to support infrastructure upgrades and expand capacity at these locations. Additional investment will go towards developing its retail, food and beverage, duty-free, and other non-aeronautical operations. 

Adani Airports aims to triple capacity by 2040

Adani Airports handled 94 million passengers, with a total capacity of 110 million, in the financial year ended 31 March 2025. The company now aims to triple its capacity to 300 million passengers annually by 2040 through phased development.

As part of this expansion, the Navi Mumbai International Airport is expected to become operational shortly, with an initial capacity of 20 million passengers and a long-term target of 90 million.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com

Hyundai exits Ola Electric, Kia trims stake in ₹6.89 bn EV sell-off

Hyundai Motor has divested its entire stake in Ola Electric, while fellow South Korean carmaker Kia has reduced its holding in the EV startup. The combined share sale netted approximately ₹6.89 billion ($80 million), news agency Reuters reported. 

According to exchange data released on Tuesday, Hyundai, which previously held a 2.47 per cent stake, sold its shares at ₹50.70 each. Kia offloaded 0.6 per cent of its stake at ₹50.55 per share. Kia originally held less than a 1 per cent stake, and its current holding remains undisclosed as the exchange data does not reveal stakes below 1 per cent.

The disposals weighed on Ola Electric’s share price, which fell by 8 per cent on Tuesday. Both sales were priced at nearly a 6 per cent discount to Monday’s closing price, contributing to the stock’s decline. 

Hyundai and Kia had initially invested $300 million in Ola Electric in 2019, with plans to collaborate on electric vehicle development and charging infrastructure alongside Bhavish Aggarwal’s startup. 

Challenges mount for Ola Electric

The divestment comes at a difficult time for Ola Electric. The company has been grappling with slowing sales, regulatory scrutiny, and intensified competition from established two-wheeler manufacturers. Since going public in August 2024, its shares have plunged 46 per cent.

Ola Electric recently reported a wider fourth-quarter loss and forecasted a revenue decline for the first quarter of the current financial year. The company has been offering steep discounts to counter competition, which has further pressured its earnings. 

Hyundai forms task force to tackle US tariffs

In April, Hyundai Motor announced the formation of a task force to address the impact of US tariffs. The company also confirmed it had moved some production of its Tucson crossover from Mexico to the United States, Reuters reported. 

Additionally, Hyundai is evaluating whether to transfer production of certain US-bound vehicles from South Korea to alternative sites.

Hyundai, along with its affiliate Kia, ranks as the world’s third-largest automaker by sales. The companies face elevated risks from US tariffs given that roughly one-third of their global sales are generated in the US market. Data from Korea Investment & Securities shows that about two-thirds of Hyundai and Kia’s US sales come from imported vehicles. 

“We expect a challenging business outlook to continue due to intensifying trade conflicts and other various unpredictable macroeconomic factors,” Hyundai said. 

The task force aims to mitigate the financial impact of tariffs and devise strategies for increasing the local sourcing of auto parts within the US.

Investments and relocation amid policy shifts

Hyundai’s move follows its $21 billion investment plan in the US, which includes expanding production at its new factory in Georgia. However, scaling up domestic output could take time, and the tariffs may cost the company billions. 

The decision to relocate some Tucson production to Hyundai’s Alabama plant is a modest step forward, with approximately 16,000 units having been built in Mexico last year.

Eqwires Research Analyst

Top-notch SEBI registered research analyst

Best SEBI registered Intraday tips provider

info@eqwires.com

Telegram Facebook Instagram

Call: +91 9624421555 / +91 9624461555

www.eqwires.com